Infectious disease occurrence, such as activation of a latent cytomegalovirus infection, was low and relatively equivalent in the two groups (Thymoglobulin 3% and Simulect 7%), as was overall graft ...
The Business Research Company's Simulect Global Market Report 2025: Growth Drivers, Share, And Trends It will grow to $XX million in 2029 at a compound annual growth ...
The India arm of Novartis AG, a multinational pharmaceutical corporation based in Switzerland, announced on October 26 that there is currently a shortage of its immunosuppressant drug 'Simulect 20 mg' ...
Nairobi — The Pharmacy and Poisons Board (PPB) has issued a public alert warning of falsified SIMULECT (basiliximab), a medication primarily used to prevent organ rejection following kidney ...
SOUTH SAN FRANCISCO, July 9 Cerimon Pharmaceuticals, Inc.,announced today it has initiated a Phase II proof-of-concept study ofSimulect(R) (basiliximab) for the treatment of noninfectious uveitis, ...
Kenya's Pharmacy and Poisons Board (PPB) has issued a public alert warning against falsified SIMULECT (basiliximab), an injectable immunosuppressive drug used to prevent kidney transplant rejection, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results